August 2014 FDA Recall Drug by Cubist Pharmaceuticals, Inc.
D-0229-2015 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Cubist Pharmaceuticals, Inc. on August 8, 2014 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0229-2015

Reason for Recall
Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.
Initiated
08-08-2014
Reported
11-05-2014
Quantity
371,879 Vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Cubist Pharmaceuticals, Inc.
Nationwide and Puerto Rico.
CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only, Single use Vial, Manufactured for: Cubist Pharmaceuticals Inc., Lexington, MA 02421, USA, NDC 67919-011-01

Batch or Lot Expiration Information

Lot# 's: CDC203, Exp 12/2015; CDC207, Exp 01/2016; CDC213, Exp 02/2016; CDC217, Exp 03/2016; CDC226, Exp 04/2016; CDC234, CDC235, Exp 05/2016; CDC243, CDC246, Exp 07/2016.